Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Sanofi

Revenue up 4% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi

3Q Revenues: €8.8 billion (+4%)

3Q Earnings: €1.9 billion (+8%)

YTD Revenues: €24.7 billion (+1%)

YTD Earnings: €5.0 billion (+3%)

Comments: Plavix sales were up 9% to €450 million in the quarter. Diabetes division sales were €1.8 billion, up 8%. Lantus sales increased 8% to €1.6 billion. Generics revenue increased 8% to €451 million reflecting the recovery in Brazil where sales were €76 million. Genzyme sales were up 25% to €649 million in the quarter driven by the growth of Aubagio and Fabrazyme. Sales grew 28% to €259 million in the U.S., 25% to €207 million in Western Europe, and 20% to €124 million in Emerging Markets. Sanofi Pasteur revenue increased 11% to €1.5 billion driven by strong performance of flu vaccines in the U.S. and in Emerging Markets as well as continued recovery of Pentacel and Adacel in the U.S.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters